• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 9, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Plan to eliminate poor vision worldwide by 2050

by Callum Glennen
October 2, 2019
in Business, Company updates & acquisitions, International, News
Reading Time: 2 mins read
A A
Share on FacebookShare on Twitter

Newly published research from Essilor has suggested an investment of US $14 billion (AU$21 b) over the next 30 years could be enough to eliminate uncorrected poor vision due to refractive errors worldwide.

Additionally, it is also believed the contribution would provide a significant return on investment by eliminating the estimated US $272 billion (AU$402 b) in productivity that is lost every year due to uncorrected vision.

The findings have been detailed in the report Eliminating poor vision in a Generation: What will it take to eliminate uncorrected refractive errors by 2050?, which was undertaken by Essilor and supported by McKinsey & Company. It was presented to international representatives on the sidelines of the recent 74th Session of the United National General Assembly.

The report calls on four areas of development: targeted investment in accessible eyecare services, investment in affordable eyecare solutions, direct funding for healthcare services and increased awareness.

Specifically, US$2.4 billion (AU$3.6 b) would be needed to create 1 million new access points for eyecare, US$0.7 billion (AU$1.0 b) for accelerating the development of innovative technologies, US$6.6 billion (AU$9.8 b) to subsidise healthcare services and US$4.5 billion (AU$6.7 b) to increase the awareness of poor vision’s cost to society.

The report cautions that if left unchecked refractive errors could reach epidic proportions, with more than half of the world’s population expected to suffer from myopia by 2050.

The burden of uncorrected refractive errors is not distributed evenly across the globe, with Africa and Asia together accounting for almost 50% of cases. This is due to a combination of high rates of refractive errors alongside limited access to eyecare services.

“While there have been many successful initiatives by both public and private actors in recent years, there is clearly a need to do more to bring good vision to everyone,” Mr Hubert Sagnières, executive vice-chairman of EssilorLuxottica and chairman of Essilor International, said.

“At the same time, there is simply no blueprint to achieve our ambition. This report will provide the necessary guidance while engaging the different stakeholders towards one goal. It illustrates our endeavour to take our efforts further by investigating this vision crisis and uncovering how to solve it. Governments, NGOs, bilateral and multilateral organisations, donors, eye care professionals and the private sector all have a role to play as we have a once in a lifetime opportunity to end a public health crisis.”

Tags: EssilorLuxotticaproductivity

Related Posts

Eyecare practitioners taking parental leave can now get relief from part of their fee to Ahpra. Image: Prostock-studio/stock.adobe.com.

Ahpra announces fee relief for practitioners on parental leave

by Staff Writer
July 9, 2025

Practitioners taking parental leave can have money back in their pockets, as Australian Health Practitioner Regulation Agency's (Ahpra) parental leave...

Image: Andrii Yalanskyi/Shutterstock.com.

People on the move – July 2025

by Staff Writer
July 9, 2025

Welcome to People on the move – July 2025, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments...

A holistic approach extends care beyond the clinical setting, and considers mental wellbeing, access to assistive technology, communication needs, and quality-of-life, SeeWay says. Image: Ievgen Skrypko/stock.adobe.com.

Beyond the diagnosis: Why holistic eye health matters more than ever

by Myles Hume
July 8, 2025

When people dealing with vision loss are supported to learn how to adapt, and feel emotionally supported, their outcomes improve...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited